Clinical role of biochemical markers of myocardial damage: Diagnosis of myocardial infarction and risk stratification;Ruolo dei marcatori biochimici di danno miocardico nella pratica clinica: Diagnosi di infarto e stratificazione del rischio

Italian Heart Journal Supplement

Volumn 1, Issue 1, 2000, Pages 54-64

  Ottani, F ^a   Galvani, M ^a   Panteghini, M ^a   Dolci, A ^a   Plebani, M ^a   Tubaro, M ^a   Zaninotto, M ^a  

^a Fondazione Cardiologica   (Italy)

Author keywords

Acute myocardial infarction; Cardiac enzymes; Troponin I; Troponin T

Indexed keywords

BIOCHEMICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; MYOGLOBIN; TROPONIN I; TROPONIN T;

CARDIOVASCULAR RISK; COST EFFECTIVENESS ANALYSIS; DISEASE MARKER; ELECTROCARDIOGRAM; FOLLOW UP; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HIGH RISK POPULATION; HUMAN; REVIEW; RISK ASSESSMENT; THORAX PAIN; WORLD HEALTH ORGANIZATION;

BIOCHEMISTRY; BIOLOGICAL MARKERS; HUMANS; ITALY; LABORATORY TECHNIQUES AND PROCEDURES; MYOCARDIAL INFARCTION; RECURRENCE; RISK ASSESSMENT; SOCIETIES, MEDICAL; TIME FACTORS;

EID: 0033734833     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. I marcatori biochimici di danno miocardico
2. Nomenclature and criteria for diagnosis of ischemic heart disease
3. Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Registration, procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents
4. International diagnostic criteria for acute myocardial infarction and acute stroke
5. New markers for early diagnosis of acute myocardial infarction
6. Assessment of the accuracy of serial electrocardiograms in the diagnosis of myocardial infarction
7. Acute coronary syndromes in the GUSTO IIb trial. Prognostic insight and impact of recurrent ischemia
8. Acute coronary syndromes: Unstable angina and non-Q wave myocardial infarction
9. Early prediction of acute myocardial infarction from clinical history, examination and electrocardiogram in the emergency room
10. Diagnostic efficiency of troponin T measurements in acute myocardial infarction
11. Metaanalysis in clinical chemistry: Validation of cardiac troponin T as a marker for ischemic heart diseases
12. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I
13. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients
14. Biochemical markers in the diagnosis of coronary artery disease
15. Implementation of serum cardiac troponin I as a marker for detection of acute myocardial infarction
16. Diagnostic marker cooperative study for the diagnosis of myocardial infarction
17. Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or non specific electrocardiograms (a report from the Multicenter Chest Pain Study)
18. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIa Investigators
19. Myoglobin in the early evaluation of acute chest pain
20. Is myoglobin useful in the diagnosis of acute myocardial infarction in the emergency department setting?
21. Value of serial myoglobin levels in the early diagnosis of patients admitted for acute myocardial infarction
22. Use of a rapid assay for subforms of creatine kinase MB to diagnose or rule out myocardial infarction
23. Comparative sensitivities and specificities of the mass measurements of CK-MB2, CK-MB, and myoglobin for diagnosing acute myocardial infarction
24. Value of myoglobin, troponin T, and CK-MB mass in ruling out an acute myocardial infarction in the emergency room
25. Biochemical markers of myocardial injury: Is MB the choice for the 1990's?
26. Biochemical markers of myocardial damage
27. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I
28. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain
29. Cardiac troponin T as a marker for myocardial ischemia in patients seen at the emergency department for acute chest pain
30. Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemical Markers of Acute Coronary Syndromes
31. Cardiac troponin I. A marker with high specificity for cardiac injury
32. Myocardial infarct expansion, infarct extension, and reinfarction: Pathophysiologic concepts
33. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group
34. Enzymatic diagnosis of acute myocardial infarction
35. Comparison of cardiac troponin I and lactate dehydrogenase isoenzymes for the late diagnosis of myocardial injury
36. Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for diagnosing acute myocardial infarction
37. The pathogenesis of coronary artery disease and the acute coronary syndromes (2)
38. Fibrinopeptide A: A marker of acute coronary thrombosis
39. Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase
40. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction
41. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41 021 patients. GUSTO I Investigators
42. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes
43. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction
44. Prognostic value of whole-blood qualitative troponin T testing in patients with acute myocardial infarction in the GUSTO III trial
45. Quantification of the prognostic role of cardiac troponins through a cumulative meta-analysis of the available clinical trials
46. Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from the TIMI II study
47. Angiographic demonstration of a common link between unstable angina pectoris and non Q-wave acute myocardial infarction
48. Coronary arteriographic findings soon after non-Q wave myocardial infarction
49. Non-transmural myocardial infarction: A comparison of hospital and late clinical course of patients with that of matched patients with transmural anterior and transmural inferior myocardial infarction
50. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research
51. Unstable angina: Outcome according to clinical presentation
52. Clinicopathologic correlations in coronary atherosclerosis. Four hundred patients studied with postmortem coronary angiography
53. Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion
54. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death
55. One year mortality outcomes of all coronary and intensive care unit patients with acute myocardial infarction, unstable angina or other chest pain in Hamilton, Ontario, a city of 375 000 people
56. The spectrum of unstable angina: Prognostic role of serum creatine kinase determination
57. Preinfarctional (unstable) angina - A prospective study - Ten year follow-up. Prognostic significance of electrocardiographic changes
58. Prognosis in unstable angina
59. Risk factors related to the 7-year prognosis for patients suspected of myocardial infarction with and without confirmed diagnosis
60. Elevated CK-MB with normal total creatine kinase in suspected myocardial infarction: Associated clinical findings and early prognosis
61. Significance of elevated MB isoenzyme with normal creatine kinase in acute myocardial infarction
62. Diagnostic and prognostic significance of minimally elevated creatine kinase-MB in patients with unstable angina
63. Creatinchinasi MB e le sue isoforme: Fisiologia ed aspetti metodologici
64. Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction
65. Increased CK-MB (mass concentration) in patients without traditional evidence of acute myocardial infarction. A risk indicator of coronary death
66. The predictive value of CK-MB mass concentration in unstable angina pectoris: Preliminary report
67. Prognostic value of cardiac troponin T in unstable angina pectoris
68. Prognostic value of troponin T, myoglobin, and CK-MB mass in patients presenting with chest pain without acute myocardial infarction
69. The prognostic value of serum troponin T in unstable angina
70. The prognostic value of serum troponin T in unstable angina
71. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
72. Time to positivity of a bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: A Thrombolysis in Myocardial Infarction (TIMI) 11A substudy
73. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina
74. The role of cardiac troponin T and other new biochemical markers in evaluation and risk stratification of patients with acute chest pain syndromes
75. Usefulness of positive troponin-T and negative creatine kinase levels in identifying high-risk patients with unstable angina pectoris
76. Direct comparison of early elevations of cardiac troponin T and I in patients with clinical unstable angina
77. Concurrent elevations of cross-linked fibrin degradation products identify high-risk of coronary events in patients with acute coronary syndromes and elevated troponin I
78. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial Ischemia
79. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC Study Group
80. Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies
81. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris
82. Prognostic implications of detection of troponin I in patients with unstable angina pectoris
83. Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris
84. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina
85. Very early risk stratification using combined ECG and biochemical assessment in patients with unstable coronary artery disease. A Thrombin Inhibition in Myocardial Ischemia (TRIM) substudy. The TRIM Study Group
86. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group
87. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels